In COVID-19 patients, two (9.6%), eighteen (24.3%) patients were tested with abnormal ALT and AST results respectively, and no significant difference was observed in the two tests among the three group (p>0.05) (Table 2). This evidence concerns the gene GPT and COVID-19.